Scientific Publications

The landmark research of BostonGene underscores the importance of combining innovative multi-platform analytics with cutting-edge software to improve patient outcomes. Explore our scientific publications to learn more.

Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma
Blood Cancer Journal, 2023
Spatial Mapping of Human Hematopoiesis at Single Cell Resolution Reveals Aging-Associated Topographic Remodeling
Blood, 2023
Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma
Science Translational Medicine, 2023
Generation and Application of a Living T-Cell Lymphoma Patient-Derived Tumor Xenograft Biorepository
HemaSphere, 2023
A Living Patient-Derived Biorepository Fostering Microenvironment Dissection in T-cell Lymphoma
HemaSphere, 2023
Longitudinal Molecular Analysis of Tumor Exome and Transcriptome to Evaluate Clonal Evolution and Identify Novel Therapeutic Targets in Thymoma
JCO Precision Oncology, 2023
IL-8 correlates with nonresponse to neoadjuvant nivolumab in HPV positive HNSCC via a potential extracellular vesicle miR-146a mediated mechanism
Molecular Carcinogenesis, 2023
Immune-depleted Tumor Microenvironment is Associated With Poor Outcomes and BTK Inhibitor Resistance in Mantle Cell Lymphoma
Hematological Oncology, 2023
Final Result of DIAL (NCI10089), Randomized Phase 2 trial of Varlilumab combined with Nivolumab in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma
Hematological Oncology, 2023
TIGIT is a key inhibitory checkpoint receptor in lymphoma
Journal for ImmunoTherapy of Cancer, 2023
Contact us